Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,658,251
+$377,060 QoQ
Shares Held
104,424
+10.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#269
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $38,102,659 across 31 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
317,729 | $10,764,656 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
11,689 | $6,333,449 | |
| 3 | ZTS |
Zoetis Inc.
|
85,213 | $6,123,404 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
23,904 | $4,028,778 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
31,533 | $2,610,301 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
496,836 | $2,449,401 | |
| 7 | VTRS |
Viatris Inc
This page
|
104,424 | $1,658,251 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
62,505 | $1,538,247 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,658,251 | 104,424 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,281,191 | 94,833 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,440,812 | 115,728 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,033,508 | 104,395 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $544,675 | 60,994 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,289,685 | 377,691 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,957,903 | 317,904 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,796,236 | 326,980 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,637,638 | 342,205 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,658,772 | 306,430 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $713,230 | 65,857 | Shares | Defined | 2024-08-15 | |
| 2023-09-30 | $663,784 | 67,321 | Shares | Defined | 2024-08-15 | |
| 2023-06-30 | $645,077 | 64,637 | Shares | Defined | 2024-08-15 | |
| 2023-03-31 | $606,800 | 63,077 | Shares | Defined | 2024-08-15 | |
| 2022-12-31 | $968,888 | 87,052 | Shares | Defined | 2024-08-15 | |
| 2022-09-30 | $747,211 | 87,701 | Shares | Defined | 2024-08-15 | |
| 2022-06-30 | $913,925 | 87,290 | Shares | Defined | 2024-08-15 | |
| 2022-03-31 | $699,648 | 64,306 | Shares | Defined | 2024-08-15 | |
| 2021-12-31 | $907,497 | 67,073 | Shares | Defined | 2024-08-30 | |
| 2021-09-30 | $999,420 | 73,758 | Shares | Defined | 2024-08-30 | |
| 2021-06-30 | $933,779 | 65,345 | Shares | Defined | 2024-08-30 | |
| 2021-03-31 | $1,003,213 | 71,812 | Shares | Defined | 2024-08-30 | |
| 2020-12-31 | $1,203,969 | 64,246 | Shares | Defined | 2024-08-30 | |
| No filing history on record for this holder in this stock. | ||||||